Key Performance
More- Earnings Score: N/A
- Momentum Score: 13
- True Yield: N/A
- Financial Health Score: N/A
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
GE HealthCare: 3 Key Takeaways for Long-Term Investors
GE HealthCare raised its full-year 2026 organic revenue guidance to 4% and reported 6.2% organic revenue growth in Q3 2026. The company's equipment backlog grew 12% year-over-year to $23.7 billion. Key strengths include recurring revenue from its Pharmaceutical Diagnostics division, operational improvements through the Heartbeat operating system, and multiyear supply agreements for memory chips that provide manufacturing resilience amid industry shortages.
11/11/2026, 5:00 PM • The Motley Fool
The global medical imaging workstations market is estimated at USD 6.20 billion in 2026 and projected to reach USD 12.55 billion by 2036, expanding at a CAGR of 7.3%. Growth is driven by rising chronic disease prevalence, digital imaging infrastructure investments, AI integration, and enterprise imaging adoption. Key challenges include high costs, cybersecurity risks, and radiologist shortages, while opportunities exist in cloud-based solutions and emerging markets.
11/06/2026, 10:59 AM • GlobeNewswire
The global computed tomography market is experiencing significant innovation driven by photon-counting technology, AI integration, and mobile imaging systems. Despite market maturity and coverage challenges, these advances are expanding access to CT imaging across hospitals, clinics, and emerging care settings including veterinary and dental applications. Key manufacturers are competing on slice count, AI capabilities, and spectral imaging technologies.
10/23/2026, 10:00 AM • GlobeNewswire
The global digital X-ray market is projected to grow from $5.79 billion in 2025 to $9.90 billion by 2036, expanding at a 5.09% CAGR. Growth is driven by the transition from analog to digital systems, adoption of mobile and retrofit solutions, AI-enabled workflows, and detector innovations. North America leads the market, while Asia-Pacific presents significant expansion opportunities. Key challenges include workforce shortages and integration complexity.
10/16/2026, 6:00 AM • GlobeNewswire
The global mobile X-ray systems market is projected to grow from $2.06 billion in 2025 to $4.00 billion by 2036, with a CAGR of 6.30%. Growth is driven by rising chronic disease prevalence, increasing hospitalization rates, and demand for point-of-care imaging. Digital systems dominate with 91.57% market share, while handheld/ultra-portable systems are the fastest-growing segment. Asia-Pacific leads regional growth at 7.43% CAGR, followed by North America and Europe.
10/16/2026, 5:58 AM • GlobeNewswire
The global mobile C-arm market is projected to grow from $2.09 billion in 2025 to $3.71 billion by 2036, expanding at a 5.35% CAGR. Growth is driven by rising adoption of minimally invasive surgery, AI integration, 3D imaging, and aging populations. North America leads the market, with hospitals as the primary end-users. Key challenges include high capital costs and shortage of skilled professionals, while advanced storage and archiving capabilities present significant growth opportunities.
10/16/2026, 5:54 AM • GlobeNewswire
The Law Offices of Frank R. Cruz is investigating GE HealthCare Technologies for potential federal securities law violations. The investigation follows the company's April 2026 earnings report, which revealed a PDx supplier recall that impacted profit performance and margins, leading to reduced full-year EPS guidance and a 13.2% stock price decline. The company's CFO also stepped down in July 2026.
10/02/2026, 5:30 PM • GlobeNewswire
The global Software as a Medical Device (SaMD) market is projected to grow from USD 2.10 billion in 2025 to USD 8.90 billion by 2034, expanding at a CAGR of 17.4%. Growth is driven by AI-enabled diagnostics, digital therapeutics, cloud-based deployment, and maturing regulatory pathways. Diagnostic and screening software leads with 42% market share, while radiology applications dominate at 34%. North America holds 45% of the market, with Asia-Pacific expected to record the fastest growth.
09/17/2026, 6:51 AM • GlobeNewswire
Ultrasound AI Market Size to Surge to USD 22.03 Billion by 2035 at a CAGR of 26.62% – SNS Insider
The global Ultrasound AI market is projected to grow from USD 2.09 billion in 2025 to USD 22.03 billion by 2035, with a CAGR of 26.62%. Growth is driven by deep learning advancements, point-of-care imaging adoption, and sonographer shortages. North America leads with 45.54% market share, while Asia-Pacific shows the fastest growth at 28.57% CAGR. Hardware dominates at 48% market share, with software as the fastest-growing segment.
09/16/2026, 8:30 PM • GlobeNewswire
The Enterprise Imaging Solutions Market is projected to grow from USD 2.32 billion in 2025 to USD 6.69 billion by 2035, with a CAGR of 11.18%. Growth is driven by cloud-native platforms, AI-driven workflows, and vendor consolidation. North America leads with 44% market share, while Asia-Pacific shows the fastest growth at 15% CAGR. Software remains the largest component at 58% share, with cloud deployment and services as the fastest-growing segments.
09/10/2026, 8:30 PM • GlobeNewswire
AI, Cybersecurity, and Interoperable Systems: Core Pillars Driving the Smart Hospital Evolution
The global Smart Hospitals Market is projected to grow from USD 90.82 billion in 2026 to USD 206.71 billion by 2032, with a CAGR of 14.56%. Growth is driven by AI integration, connected medical devices, and digital health initiatives across APAC, Europe, and North America. Key focus areas include precision medicine, operational efficiency, and cybersecurity implementation.
07/08/2026, 4:20 AM • GlobeNewswire
The global infant heart monitor market is projected to grow from USD 2.83 billion in 2025 to USD 7.93 billion by 2035, at a CAGR of 10.85%. Growth is driven by advancements in wearable medical technologies, rising adoption of remote monitoring, increased incidence of congenital heart defects, and expansion of healthcare infrastructure in emerging markets. North America leads the market while Asia-Pacific is expected to witness the fastest growth.
07/06/2026, 3:30 PM • GlobeNewswire
The global neonatal infant care market, valued at USD 3.06 billion in 2025, is expected to grow to USD 5.59 billion by 2035 at a CAGR of 6.21%. Growth is driven by rising preterm births, increasing neonatal complications, and technological innovations in monitoring and respiratory support systems. Hospitals and NICUs dominate the market, with incubators and ventilators as leading product categories.
07/01/2026, 7:30 PM • GlobeNewswire
The global healthcare command centers market is projected to grow from USD 1.8 billion in 2024 to USD 5.0 billion by 2034, with a CAGR of 10.8%. Growth is driven by rising demand for efficient patient flow management, digital transformation in hospitals, and operational optimization. Cloud-based deployment dominates with 49% market share, while software components lead with 48% share. North America holds 41% of the global market. However, high implementation costs and limited adoption in developing regions pose challenges.
06/18/2026, 12:50 PM • GlobeNewswire
GE HealthCare reported Q1 2026 earnings that missed consensus estimates and cut full-year guidance due to a PDx supplier issue. The stock declined 13% following the announcement. Law firm Kirby McInerney LLP is investigating potential securities law violations by the company and its senior management.
05/21/2026, 7:00 PM • GlobeNewswire
Peers
Statistics
MoreInformation as of 11/11/2026
Company Profile
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.